Skip to content

Lowering the glycaemic index of white bread using a white bean extract

Lowering the glycaemic index of white bread using a white bean extract: an open-label crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50347345
Enrollment
16
Registered
2009-08-19
Start date
2005-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycaemic index measurements Not Applicable

Interventions

This is an open-label six-arm crossover study with 13 randomised healthy adults. Standardised testing of the glycaemic index was performed on white bread with and without the addition of the white bea
39) inhibiting units (Pharmachem Laboratories, Kearny, NJ). The white bread was Wonder brand (Interstate Bakeries, Kansas City, MO). Subjects reported to the study centre seven times during which they

Sponsors

Pharmachem Laboratories, Inc (USA)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Aged between 24 and 44 years, males only 2. Body mass index (BMI) between 18 and 25 (kg/m^2) 3. Fasting glucose levels less than or equal to 100 mg/dL 4. Agreed to all study visits and procedures 5. Agreed to use appropriate forms of birth control if females of child bearing potential

Exclusion criteria

Exclusion criteria: 1. Any active eating disorders 2. Gastrointestinal illness 3. History of gastrointestinal surgery, diabetes or other endocrinological disorders

Design outcomes

Primary

MeasureTime frame
Glycaemic index calculated according to the Food and Agriculture Organization (FAO)/World Health Organization (WHO) standard, using capillary blood glucose measurements. Glucose measured seven times over 2 hours on each study day.

Secondary

MeasureTime frame
Tolerability of the white bean extract measured using 10 point Likert scales for diarrhoea, flatulence, abdominal bloating, abdominal cramping, nausea, boborygmi (bowel sounds) and soft stools. Glucose measured seven times over 2 hours on each study day.

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026